Cargando…
A soluble guanylate cyclase activator protects from diabetic nephropathy beyond standard of care in the ZSF1 rat
Autores principales: | Pullen, Steven S, Lincoln, Kathleen A, Harrison, Paul C, Chen, Hongxing, Wang, Hong, Clifford, Holly, Qian, HuSheng, Wong, Diane, Sarko, Chris, Brenneman, Jehrod, Fryer, Ryan, Richman, Jeremy, Reinhart, Glenn A, Boustany, Carine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565540/ http://dx.doi.org/10.1186/2050-6511-16-S1-A4 |
Ejemplares similares
-
Effects of soluble guanylate cyclase stimulator on renal function in ZSF-1 model of diabetic nephropathy
por: Hu, Lufei, et al.
Publicado: (2022) -
Structural studies of soluble guanylate cyclase
por: Macdonald, Jane, et al.
Publicado: (2009) -
Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase
por: Sharma, Arpeeta, et al.
Publicado: (2023) -
Soluble Guanylate Cyclase Stimulators in Heart Failure
por: Kansakar, Sajog, et al.
Publicado: (2021) -
Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma
por: Buys, Emmanuel S., et al.
Publicado: (2014)